Skip to main content
Caplight Logo









ReVision Implant

ReVision Implant

Private
BelgiumHealthcare & Life Scienceshttps://www.revision-implant.com/

Last Round

Seed

May 26, 2026

Total Funding Raised

$7.3M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

ReVision Implant is a neurotechnology company developing a cortical visual prosthesis to restore functional vision in people with severe blindness by transmitting video directly to the brain's visual cortex.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Clinical Trials, Biotechnology, Sensors

Business Model

B2B

Customer Profile

Hardware Sales, Hardware + Subscription, Government Contracts

AI Layer

Non-AI

Keywords

cortical visual prosthesisBCIbrain-computer interfacebionic eyevision restorationbrain implantneurotechnologyvisual neuroprosthesisneurostimulationmedical deviceblindness treatmentvisual cortex stimulationmicro-electrode arrayFDA Breakthrough Deviceclinical trials

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

ReVision Implant Comparables

Compare ReVision Implant with similar companies based on industry and business-model similarity.

ReVision Implant comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Phosphoenix
93%
Vivani Medical
82%
Neuralink
75%

ReVision Implant Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedMay 26, 2026
GrantJan 11, 2025

Key People

Founding team and executive leadership

Frederik Ceyssens

Founder & CEO

Founding Team

Maarten Schelles

CTO

Executive Team

ReVision Implant Investors

Notable investors and investment history

ReVision Implant investors
InvestorRounds
European Innovation Council FundGrant
Plug and Play Tech CenterSeed
imec.istartSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 26, 2026

    $4.65M raised in early funding.

  • Feb 16, 2026

    Grew 67% QoQ, from 6 to 10 employees.

Recent news

Latest coverage and updates

  • is_developingJul 25, 2026

    Revision Implant is developing neural implant system targeting the visual cortex.

ReVision Implant Filings

Explore SEC and related filing metadata, where available.

ReVision Implant filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about ReVision Implant's valuation, stock price, and market status.

Is ReVision Implant a public or private company?

ReVision Implant is a private company.

What is the current stock price of ReVision Implant?

ReVision Implant is a private company with no public stock price. No recent secondary market data is available.

How much is ReVision Implant worth (valuation)?

Valuation information for ReVision Implant is not publicly available.

Can I buy ReVision Implant stock?

ReVision Implant shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was ReVision Implant's last funding round?

ReVision Implant's most recent funding round was Early Funding on May 26, 2026.

Who are the main investors in ReVision Implant?

Investor information for ReVision Implant is not publicly disclosed.

Will ReVision Implant IPO soon?

No public IPO plans have been announced for ReVision Implant.

How can I track ReVision Implant secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor ReVision Implant's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersBelgium
Employee Range10
Year Founded2020
Last FundingMay 26, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?